Lucas Ward
Stock Analyst at Ascendiant Capital
(0.64)
# 4,044
Out of 5,053 analysts
21
Total ratings
28.57%
Success rate
-27.46%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HSCS HeartSciences | Maintains: Buy | $15 → $9 | $2.61 | +244.83% | 3 | Oct 1, 2025 | |
| ACON Aclarion | Maintains: Buy | $20 → $22 | $7.23 | +204.29% | 4 | Sep 19, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $6.2 → $6.5 | $2.57 | +152.92% | 4 | Sep 9, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Maintains: Buy | $7 → $3 | $1.23 | +143.90% | 3 | Sep 3, 2025 | |
| LIQT LiqTech International | Maintains: Buy | $3.4 → $3.6 | $2.25 | +60.32% | 5 | Jun 16, 2025 | |
| VMAR Vision Marine Technologies | Maintains: Buy | $3,375 → $2,700 | $1.22 | +221,211.48% | 2 | Jul 29, 2024 |
HeartSciences
Oct 1, 2025
Maintains: Buy
Price Target: $15 → $9
Current: $2.61
Upside: +244.83%
Aclarion
Sep 19, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $7.23
Upside: +204.29%
Vivos Therapeutics
Sep 9, 2025
Maintains: Buy
Price Target: $6.2 → $6.5
Current: $2.57
Upside: +152.92%
60 Degrees Pharmaceuticals
Sep 3, 2025
Maintains: Buy
Price Target: $7 → $3
Current: $1.23
Upside: +143.90%
LiqTech International
Jun 16, 2025
Maintains: Buy
Price Target: $3.4 → $3.6
Current: $2.25
Upside: +60.32%
Vision Marine Technologies
Jul 29, 2024
Maintains: Buy
Price Target: $3,375 → $2,700
Current: $1.22
Upside: +221,211.48%